Structure of the human κ-opioid receptor in complex with JDTic

被引:697
作者
Wu, Huixian [1 ]
Wacker, Daniel [1 ]
Mileni, Mauro [1 ]
Katritch, Vsevolod [1 ]
Han, Gye Won [1 ]
Vardy, Eyal [2 ,3 ]
Liu, Wei [1 ]
Thompson, Aaron A. [1 ]
Huang, Xi-Ping [2 ,3 ]
Carroll, F. Ivy [4 ]
Mascarella, S. Wayne [4 ]
Westkaemper, Richard B. [5 ]
Mosier, Philip D. [5 ]
Roth, Bryan L. [2 ,3 ]
Cherezov, Vadim [1 ]
Stevens, Raymond C. [1 ]
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Univ N Carolina, Chapel Hill Med Sch, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Dept Pharmacol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Chapel Hill Med Sch, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA
[4] Res Triangle Inst, Ctr Organ & Med Chem, Res Triangle Pk, NC 27709 USA
[5] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA
关键词
PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEINS; OPIATE RECEPTOR; SALVINORIN-A; IN-VITRO; DOCKING; AGONIST; ANALOGS;
D O I
10.1038/nature10939
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Opioid receptors mediate the actions of endogenous and exogenous opioids on many physiological processes, including the regulation of pain, respiratory drive, mood, and-in the case of kappa-opioid receptor (kappa-OR)-dysphoria and psychotomimesis. Here we report the crystal structure of the human kappa-OR in complex with the selective antagonist JDTic, arranged in parallel dimers, at 2.9 angstrom resolution. The structure reveals important features of the ligand-binding pocket that contribute to the high affinity and subtype selectivity of JDTic for the human kappa-OR. Modelling of other important kappa-OR-selective ligands, including the morphinan-derived antagonists norbinaltorphimine and 5'-guanidinonaltrindole, and the diterpene agonist salvinorin A analogue RB-64, reveals both common and distinct features for binding these diverse chemotypes. Analysis of site-directed mutagenesis and ligand structure-activity relationships confirms the interactions observed in the crystal structure, thereby providing a molecular explanation for kappa-OR subtype selectivity, and essential insights for the design of compounds with new pharmacological properties targeting the human kappa-OR.
引用
收藏
页码:327 / U69
页数:8
相关论文
共 50 条
[1]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[2]  
Ballesteros J. A., 1995, Neuroscience Methods, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471]
[3]  
Befort K, 1996, MOL PHARMACOL, V49, P216
[4]  
Bricogne G, 2009, BUSTER V 2 8 0
[5]   Crystallizing membrane proteins using lipidic mesophases [J].
Caffrey, Martin ;
Cherezov, Vadim .
NATURE PROTOCOLS, 2009, 4 (05) :706-731
[6]   Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-Hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) [J].
Cai, Tingwei Bill ;
Zou, Zhou ;
Thomas, James B. ;
Brieaddy, Larry ;
Navarro, Hernan A. ;
Carroll, F. Ivy .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) :1849-1860
[7]   Kappa-opioid ligands in the study and treatment of mood disorders [J].
Carlezon, William A., Jr. ;
Beguin, Cecile ;
Knoll, Allison T. ;
Cohen, Bruce M. .
PHARMACOLOGY & THERAPEUTICS, 2009, 123 (03) :334-343
[8]   Pharmacological properties of JDTic:: a novel κ-opioid receptor antagonist [J].
Carroll, I ;
Thomas, JB ;
Dykstra, LA ;
Granger, AL ;
Allen, RM ;
Howard, JL ;
Pollard, GT ;
Aceto, MD ;
Harris, LS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 501 (1-3) :111-119
[9]   SPECIFIC RECEPTOR FOR THE OPIOID PEPTIDE DYNORPHIN - STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
CHAVKIN, C ;
GOLDSTEIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10) :6543-6547
[10]   Mutation of a single TMVI residue, Phe282, in the β2-adrenergic receptor results in structurally distinct activated receptor conformations [J].
Chen, SH ;
Lin, F ;
Xu, M ;
Riek, RP ;
Novotny, J ;
Graham, RM .
BIOCHEMISTRY, 2002, 41 (19) :6045-6053